In general, the M 2 subtype of muscarinic acetylcholine receptors has the highest sensitivity for allosteric modulators and the M 5 subtype the lowest. The M 2 /M 5 selectivity of some structurally diverse allosteric agents is known to be completely explained by M 2 177 Tyr and M 2 423 Thr in receptors whose orthosteric site is occupied by the conventional ligand N-methylscopolamine (NMS Trp by alanine revealed a pronounced contribution of these epitopes to subtype independent baseline affinity in NMSbound and NMS-free receptors for all agents except diallylcaracurine V. In a few instances, this tryptophan also influenced cooperativity and subtype selectivity. Docking simulations using a three-dimensional M 2 receptor model revealed that the aromatic rings of M 2 177 Tyr and M 2 422 Trp, in a concerted action, might fix one of the aromatic moieties of alkane-bisammonio compounds between them. Thus, M 2 422 Trp and the spatially adjacent M 2 177 Tyr, as well as M 2 423 Thr, form a cluster of amino acids within the allosteric binding cleft that is pivotal for both M 2 /M 5 subtype selectivity and baseline affinity of allosteric agents.
Replacement of M 2
422 Trp and of the corresponding M 5 477 Trp by alanine revealed a pronounced contribution of these epitopes to subtype independent baseline affinity in NMSbound and NMS-free receptors for all agents except diallylcaracurine V. In a few instances, this tryptophan also influenced cooperativity and subtype selectivity. Docking simulations using a three-dimensional M 2 receptor model revealed that the aromatic rings of M 2 177 Tyr and M 2 422 Trp, in a concerted action, might fix one of the aromatic moieties of alkane-bisammonio compounds between them. Thus, M 2 422 Trp and the spatially adjacent M 2 177 Tyr, as well as M 2 423 Thr, form a cluster of amino acids within the allosteric binding cleft that is pivotal for both M 2 /M 5 subtype selectivity and baseline affinity of allosteric agents.
All five subtypes of muscarinic acetylcholine receptors contain an allosteric site apart from the orthosteric site that is addressed by acetylcholine and conventional muscarinic agonists and antagonists. Binding of an allosteric modulator allows formation of ternary complexes consisting of the allosteric agent, the orthosteric ligand, and the receptor protein. Through ternary complex formation, allosteric agents may evoke particular actions that cannot be induced by orthosteric ligands alone and that may have therapeutic potential. For instance, allosteric modulators may increase the binding of orthosteric agonists or antagonists (positive cooperativity) or they may inhibit orthosteric ligand binding (negative cooperativity). In either case, the magnitude of the cooperativity will define an intrinsic limit on the magnitude of the positive or negative effect, in marked contrast to the unconstrained action of orthosteric agonists and antagonists. It is also possible for allosteric modulators to leave orthosteric ligand binding unchanged (neutral cooperativity) while nevertheless changing the kinetics of binding (Ellis, 1997; Christopoulos and Kenakin, 2002; Krejčí et al., 2004; Soudijn et al., 2004; Birdsall and Lazareno, 2005; Wess, 2005) . Finally, in addition to modulating orthosteric ligand binding properties, allosteric agents also may modulate agonist induced intrinsic efficacy (Zahn et al., 2002) . A better understanding of the molecular topology and mechanisms of allosteric agent binding and action will help to design new allosteric agents with improved properties and will lead to a better insight into the principles of muscarinic receptor function. The M 2 subtype of muscarinic receptors generally displays highest affinity for allosteric modulators, whereas the M 5 subtype has lowest sensitivity. A rather good insight into the allosteric binding area has now been achieved by combining three strategies [i.e., development of allosteric agents with high affinity and selectivity for M 2 receptors that presumably fit tightly in a fixed position at the receptor protein , receptor mutagenesis starting from M 2 /M 5 chimeric receptor constructs to identify essential epitopes for allosteric agent binding (Ellis et al., 1993; Gnagey et al., 1999; Buller et al., 2002; Huang et al., 2005) , and generation of a three-dimensional M 2 receptor model based on the crystal structure of the inactive bovine rhodopsin (Jö hren and Hö ltje, 2002; Voigtlä nder et al., 2003) ]. This approach has allowed the visualization of different binding topologies for typical and atypical allosteric agents (Trä nkle et al., 2005; Wess, 2005) . However, the mode by which certain epitopes affect binding affinity of allosteric agents is still in question. For instance, an amino acid may directly serve as a docking point or alternatively constitute a sterical hindrance, or it may indirectly contribute to ligand binding by governing the conformation of amino acid strands that contain a relevant point of attachment. We have found that two amino acids are sufficient to account completely for the 100-fold M 2 /M 5 selectivity of structurally different allosteric agents . These amino acids are M 2 177 Tyr and M 2 423 Thr, corresponding to the M 5 amino acids 184 Gln and 478 His. The receptor model suggested M 2 423 Thr to be a direct docking point for caracurine V-type agents. For alkane-bisammonio-type compounds such as W84 (Fig. 1) , however, the model suggested an indirect influence, in that M 2 423 Thr induces a favorable spatial adjustment of the adjacent M 2 422 Trp for its interaction with one of the phthalimide moieties of W84. The involvement of M 2 422 Trp is supported by a broad mutagenesis study by Matsui et al. (1995) , who found the corresponding tryptophan of M 1 to be relevant to the binding of the allosteric agent gallamine. Therefore, we set out to clarify the role of this conserved tryptophan and its neighboring M 2 423 Thr or M 5 478 His. As a major outcome of this study, we found that this tryptophan is of crucial importance for M 2 /M 5 subtype independent baseline affinity of alkane-bisammonio type allosteric modulators and of gallamine. Thus, an epitope of high relevance to M 2 /M 5 subtype independent baseline affinity of allosteric agents has been discovered. Furthermore, we found that this tryptophan in certain instances may provide subtype selectivity for allosteric agents or may modulate their cooperativity with an orthosteric antagonist. Taken together, the findings reveal that relevant epitopes for subtype dependent and subtype independent allosteric agent binding are clustered in close spatial proximity at the junction between the allosteric and the orthosteric binding areas of muscarinic acetylcholine receptors. 
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Materials and Methods
Materials
Atropine sulfate, gallamine triethiodide, and N-methylscopolamine bromide were obtained from Sigma-Aldrich (Steinheim, Germany). W84 is commercially available from Tocris Cookson Inc. (St. Louis, MO). Dimethyl-W84 (Trä nkle et al., 1998) , naphmethonium (Muth et al., 2003) and diallylcaracurine V (Zlotos et al., 2000) 
Mutagenesis and Expression
Point-mutated M 2 and M 5 receptors were generated as described previously Huang et al., 2005) using the QuikChange site-directed mutagenesis kit (Stratagene, Amsterdam, The Netherlands). pCD plasmids, including wild-type genes for human M 2 and M 5 muscarinic receptors, served as templates in polymerase chain reaction. Mutations were inserted by addition of synthetic oligonucleotide primers containing the required triplet changes (Sigma Genosys, Steinheim, Germany). Primers were elongated during temperature cycling by a high-fidelity DNA polymerase. After amplification over 12 to 16 cycles, the parental DNA was digested by a methylation-specific endonuclease, thus selecting the mutated plasmids. The polymerase chain reaction products were transformed into supercompetent Escherichia coli cells. Bacteria were plated on ampicillin-containing agar and incubated overnight. Clones with the putative mutation were isolated and grown up in 500 ml of Luria-Bertani medium (Sigma-Aldrich). Plasmids were extracted using the Plasmid Maxi kit (QIAGEN, Hilden, Germany) and mutation was confirmed by sequencing. Thereafter, wild-type or mutant plasmid-DNA was transiently transfected into COS-7 cells using PolyFect transfection reagent (QIAGEN).
Cell Culture and Membrane Preparation
COS-7 cells were cultured at 37°C under humidified air supplemented with 5% CO 2 in Dulbecco's modified Eagle's medium containing 1% penicillin-streptomycin and 10% fetal bovine serum. One day before transfection, cells were grown in 10-cm dishes by seeding 1.6 ϫ 10 6 cells per dish. Forty-eight hours after transfection, cells were harvested and homogenized in 5 mM sodium/potassium phosphate buffer (PB; 4 mM Na 2 HPO 4 and 1 mM KH 2 PO 4 ), pH 7.4. After centrifugation, membranes were resuspended in 5 mM PB and stored in aliquots at Ϫ80°C.
Dissociation Binding Assays
Two-point [
3 H]NMS dissociation experiments were performed in 5 mM PB, pH 7.4, at 23°C as described previously Huang et al., 2005) . Membranes with the respective wild-type or mutant M 2 or M 5 receptor were prelabeled with 1 nM radioligand for 30 min. Measurement of [ 3 H]NMS dissociation was started by the addition of 3 M atropine, with or without varying concentrations of allosteric modulator. After an appropriate time interval, depending on the [ 3 H]NMS dissociation half-time of the respective receptor, dissociation was terminated by filtration using a Brandel cell harvester and GMF2 glass microfiber sheets (Sartorius, Göttingen, Germany), saturated with 0.1% polyethylenimine. Filtration was immediately followed by two rinses with ice-cold 40 mM PB. Filter-bound radioactivity was detected by liquid scintillation counting. Nonspecific binding of [ 3 H]NMS was determined in the presence of 3 M atropine.
Equilibrium Binding Assays
[ 3 H]NMS equilibrium binding was measured in the presence of 0.2 nM radioligand and the indicated concentrations of the allosteric agent, as described previously . Experiments were conducted in 5 mM PB, pH 7.4, at 23°C, and incubation was carried on until equilibrium binding was achieved. The incubation time sufficient to attain equilibrium was calculated according to equation 31 in Lazareno and Birdsall (1995) .
The affinity of the orthosteric probe [ 3 H]NMS for the wild-type and mutant receptors was determined in homologous competition experiments. For this purpose, membranes were incubated with 0.2 nM radioligand and unlabeled NMS (1 pM to 30 nM) for the same period, as applied in the equilibrium binding experiment with the allosteric agent. Filtration and quantification of membrane-bound radioligand were carried out as described above.
Data Analysis
Data from dissociation experiments were converted into apparent rate constants assuming monoexponential decay. The apparent rate constant obtained in the absence of allosteric modulator served as control, and the rate constants determined in the presence of each concentration of allosteric agent were expressed as a percentage of that control value. This percentage was then plotted against the log concentration of the modulator. Curve fitting by nonlinear regression analysis was based on a four-parameter logistic function as described by Trä nkle and Mohr (1997) . The resulting concentration-effect curves for the allosteric delay of [ 3 H]NMS dissociation reflect the binding of the allosteric agent to the NMS-occupied receptors. When there was no significant difference (F-test, p Ն 0.05) between the top plateau of the curve and the control value k Ϫ1 ϭ 100%, or between the bottom plateau of the curve and k Ϫ1 ϭ 0%, plateaus were fixed at 100% and 0%, respectively. The negative logarithm of the concentration inducing a half-maximal reduction of the NMS dissociation rate, pEC 0.5,diss , indicates the affinity of the allosteric agent for the NMSoccupied receptor.
[ 3 H]NMS equilibrium binding data were analyzed according to the ternary complex model of allosteric interactions (Stockton et al., 1983; Ehlert, 1988) 3 H]NMS dissociation approximately 2 h). W84 is known to be sensitive to spontaneous hydrolytic cleavage (t 1/2 ϭ 11 h; Schulz, 1998) ; the concentration values indicated for W84 represent effective concentrations calculated on the basis of the half-time of the decay and the applied incubation time. In the case of almost neutral cooperativity (␣ Ϸ 1), [ 3 H]NMS equilibrium binding remains nearly unchanged under the influence of increasing concentrations of the allosteric modulator. Under this condition, curve fitting with eq. 1 does not work. Because the validity of the cooperativity model can be assumed (e.g., Ellis, 1997; Trä nkle et al., 1998; Raasch et al., 2002 ) the affinity of the allosteric agent to the NMS-occupied receptors pEC 0.5,diss is identical to p(␣ ⅐ K A ). Therefore, we replaced K A in eq. 1 with EC 0.5,diss /␣ (Raasch et al., 2002) . EC 0.5,diss was derived from preceding dissociation experiments, and curve fitting yielded the cooperativity factor ␣, 
Three-Dimensional Modeling and Docking Simulations
Homology Modeling. As template for the model, the latest X-ray structure of bovine rhodopsin (Protein Data Bank accession 1U19; Okada et al., 2004 ) with a resolution of 2.2 Å was used. The sequences of the human M 2 receptor and the bovine rhodopsin were extracted from SwissProt [codes P08172 (Bonner et al., 1987) and P02699 (Nathans and Hogness, 1983) , respectively]. The sequence alignment was carried out with ClustalW (Thompson et al., 1994) as well as based on the pinpoints identified by Baldwin et al. (1997) . Transmembrane regions of the M 2 receptor were detected using several secondary structure prediction methods. The extracellular and intracellular loops and the N terminus, respectively, were created by the application of a loop search routine based on an ␣-carbon distance-matrix as implemented in the Homology module of Insight II 2000 (Accelrys, San Diego, CA). The three-dimensional coordinates for the C terminus were added in analogy to the X-ray structure of bovine rhodopsin.
Receptor-Ligand Complex. The orthosteric ligand N-methylscopolamine and the allosteric agent W84 were manually docked. The W84 conformation used in the docking procedure was the one that had been detected as the most favorable one in the course of a dynamic conformational search in aqueous environment . Two steps were used to reach a good starting geometry for the following molecular dynamics simulation. First, the free volume located between the helices and the extracellular loops was calculated using the program SURFNET (Laskowski, 1995) . In the second step, the large cavities were analyzed using GRID interaction fields (Goodford, 1985) . Different GRID probes were applied to mimic the functional groups present in the ligands; afterward, the ligands were manually docked according to the favorable positions detected by GRID.
Molecular Dynamics Simulation. For further refinement and structure validation, molecular dynamics simulations were carried out using the software package GROMACS (Lindahl et al., 2001) . For this purpose, the model was embedded in a phospholipid bilayer with aqueous phases containing Na ϩ and Cl Ϫ as counter-ions both extraand intracellularly. Schlegel et al. (2005) recently described this procedure. Position restraints were initially set on the ternary complex with a force of 5000 kJ ⅐ mol Ϫ1 ⅐ nm Ϫ2 to equilibrate the membrane and solvent molecules. Afterward the position restraints were slowly reduced in 10 steps of 100 ps each until an unconstrained dynamics simulation over a period of 2500 ps was carried out. Frames were written out for every 2 ps.
Model Quality Check. The molecular dynamics simulation was checked for equilibration of the protein and its stability. The intramolecular interaction energy of the protein and the root-meansquare deviation of the entire and helical backbone and of W84, respectively, were taken as measures for complex equilibration. The program g_cluster implemented in GROMACS was applied to attain a representative structure from the trajectory after equilibration. This structure was minimized using the steepest descent algorithm and the protein geometry was checked with PROCHECK (Laskowski et al., 1993) .
Results
In this study, we aimed at characterizing the role for allosteric action of two conserved tryptophans located in the essential region of the allosteric binding domain of the M 2 receptor and the possible interplay with the spatially adjacent amino acids M 2 177 Tyr and M 2 423 Thr (Fig. 2) . To probe the influence of these M 2 and the respective M 5 amino acids on the binding of allosteric modulators, these residues were either replaced by the corresponding amino acids of the counterpart receptor subtype (M 2 /M 5 or M 5 /M 2 substitution) or by alanine as a neutral residue. M 2 /M 5 substitution and M 5 /M 2 substitution, respectively, provide insight into the contribution of an amino acid of interest relative to its counterpart amino acid to the high affinity of the allosteric agents at M 2 compared with M 5 , whereas substitution against alanine serves to elucidate the role of the amino acid by itself and was applied throughout in the case of conserved residues.
We first investigated the effect of point mutations on the formation of ternary complexes, which is the main characteristic of allosteric interactions. For this purpose, we employed dissociation binding experiments, using Table 1 . Dissociation half-times at the M 2 receptors ranged from 5.6 min to 56 min. At M 5 , dissociation was much slower than at M 2 , which is in accordance with data presented previously (Ellis et al., 1993; Buller et al., 2002; Voigtlä nder et al., 2003; Huang et al., 2005) . Mutation-induced changes of the half-times are mentioned in the subsequent paragraphs. 478 His has been shown in the preceding paragraph to slow NMS binding kinetics and is part of the allosteric site, we hypothesized that the histidine at this position might be an obstacle for the binding of W84 to the NMS-liganded receptor. Concentration-effect curves, displaying the allosteric interaction of W84 with the different receptor mutants, are shown in Fig. 4 . It has been reported previously ) that insertion of histidine in M 2 instead of 423 Thr lowers the potency of W84 (Ϫ0.79 log units; Fig. 4 Trp by alanine (5-fold), whereas the mutation of M 2
422
Trp to alanine increased the dissociation half- Trp seem to be important for speeding up the access of NMS to and its egress from the orthosteric binding pocket of the M 2 receptor.
In the case of W84, as mentioned above, substitution of M 2 422 Trp by alanine led to a pronounced loss of the modulator's allosteric potency. In contrast to this, replacement of M 2 427 Trp by alanine did not change the potency of the modulator significantly compared with the wild-type receptor ( Fig. 6, top; tors for the other allosteric agents (Fig. 1) . We chose two additional representatives of alkane-bisammonio type agents [i.e., dimethyl-W84, which has been developed as a radioalloster (Trä nkle et al., 1998) , and naphmethonium, which is an enhancer of NMS binding (Muth et al., 2003) ]. Furthermore, we included gallamine, which is an archetypal allosteric agent (Clark and Mitchelson, 1976; Stockton et al., 1983) , and diallylcaracurine V (Zlotos et al., 2000) . Allosteric potencies of the modulators, expressed as pEC 0.5,diss , are compiled in Table 4 , left. The alkane-bisammonio type agents (dimethyl-W84 and naphmethonium) and gallamine were quite similar to W84 in terms of their patterns of epitope dependence at M 2 . That is, replacement of M 2 422 Trp by alanine was always deleterious for the binding of the modulators, whereas mutation of M 2 427 Trp had no effect. However, in contrast with W84, there was actually an increase in potency toward diallylcaracurine V when either M 2 422 Trp or both tryptophans were substituted by alanine (Table 4 , left). This gain in potency was caused mainly by the replacement of M 2 422 Trp. It is intriguing that diallylcaracurine V seems to be exceptional in two aspects: 1) it depends directly on M 2 423 Thr, and 2) it is negatively influenced by M 2 422 Trp. Taken together, the amino acid 422 Trp is critical, either in a positive or in a negative fashion, for allosteric agent binding at the NMS-occupied M 2 receptor; depending on the agent, it may provide affinity or impair binding.
422 Trp Is Often Critical for Allosteric Agent Binding in NMS-Free M 2 Receptors. The results presented above refer to the formation of ternary complexes (i.e., the ability of allosteric test compounds to interact with NMS-occupied receptors). To gain insight into the role of the two conserved tryptophans for allosteric agent binding at NMS- (Fig. 6, top) . Thus, the lack of effect of W84 on [ 3 H]NMS equilibrium binding reflects neutral cooperativity between these ligands. The change from negative (M 2 wild type) to neutral cooperativity at the M 2 427 W3A mutant is accompanied by a small loss of affinity of W84 to the NMS-free receptor mutant relative to the NMS-free wild-type receptor (Table 4 , pK A values, right).
The affinity of naphmethonium, an enhancer of the binding of [ 3 H]NMS at M 2 (curves not shown), was considerably reduced at the M 2 422 W3A mutant, whereas the mutant M 2 427 W3A showed the same sensitivity for naphmethonium as the NMS-free wild-type M 2 receptor (Table 4 , right). Naphmethonium continued to be positively cooperative with NMS at both singly and doubly mutated receptors.
Gallamine revealed a significantly reduced binding affinity both at the NMS-free M 2 422 W3A mutant and at the M 2 427 W3A mutant relative to M 2 , although the effects were not additive (Table 4, 3 H]NMS at any M 2 receptors tested in this study. We have no explanation why the sum of p␣ and pK A was often considerably different from pEC 0.5,diss ; further investigation is needed to understand this phenomenon. In the case of diallylcaracurine V, there was no significant change of binding affinity at the NMS-free receptor mutants relative to the M 2 wild-type receptor. Taken together, the role of the tryptophans at NMSfree M 2 receptors is more complex than at the NMS-liganded , a small loss of affinity by a factor of 2 was seen. However, unlike M 2 , the kinetics of NMS dissociation remained almost unchanged; only in M 2 482 W3A, k Ϫ1 was increased by a factor of 1.4 relative to M 5 wild type. It was remarkable that the double mutation, which slowed dissociation of NMS by 8-fold in M 2 , had no effect at all in M 5 . With regard to allosteric agent binding, we first investigated the influence of both residues at NMS-occupied receptors. As mentioned above, replacement of M 5 477 Trp by alanine resulted in a pronounced reduction of potency of W84 (Fig. 7,  top) . Furthermore, we found a pronounced loss of allosteric efficacy of W84; i.e., dissociation of the orthosteric ligand could hardly be inhibited, even in the presence of highest concentrations of the allosteric modulator (lower plateau at 87%; maximum effects found in this study are compiled in Supplemental Table 1 In equilibrium binding experiments, W84 had no effect on the binding of [ 3 H]NMS at M 5 wild type and at the M 5 482 W3A mutant; i.e., the cooperativity was neutral (Fig.  7, bottom) . In contrast, replacement of M 5 477 Trp by alanine resulted in a pronounced inhibition of NMS equilibrium binding by W84; i.e., the cooperativity was negative. The pK A values shown in Table 5 reveal that the NMS-free mutant receptor M 5 477 W3A and the double mutant, but not M 5 482 W3A, displayed significantly lower sensitivity for W84 than M 5 wild type, but this loss of sensitivity was less pronounced than at the NMS-occupied receptor. Therefore, W84 exhibited strong negative cooperativity at these mutants (Table 5, right) . In the case of gallamine, only substitution of 477 Trp affected the agent's binding affinity to the NMS-free M 5 receptors ( (Jöhren and Höltje, 2002; Voigtlä nder et al., 2003) . The availability of an actual and revised bovine rhodopsin X-ray structure showing higher resolution (Okada et al., 2004) as well as progress in computational techniques made it necessary to generate a new and improved M 2 receptor model. In contrast to the preceding model, the receptor is now embedded in a phospholipid bilayer composed of dipalmitoylphosphatidylcholine with aqueous phases containing sodium ions and chloride ions as counter-ions extra-and intracellularly (Fig. 9 ). The new model was not only in good agreement with previous results but also seemed to be more suitable to explain experimental data reported previously . Because the template of this model, the X-ray structure of bovine rhodopsin, appears in its inactive state, the resulting geometry of the homology model should also be in this state and should thus be appropriate to simulate an antagonist-(NMS-) liganded receptor. As described previously Trä nkle et al., 2005 ) the orthosteric binding site is located between the transmembrane helices TM3-TM6 and is connected through a narrow channel with the allosteric binding site which is formed by the extracellular loops.
To model the ternary complex characteristic for allosteric interactions, NMS was placed in the orthosteric site. To obtain a realistic low-energy conformation for the highly flexible W84, molecular dynamics simulations were carried out in an aqueous environment as reported previously . The conformation resulting from the dynamical treatment of W84 was docked to the NMS-occupied receptor. The system showed a stable geometry during the molecular dynamics simulation. The representative structure from the molecular dynamics simulation was of good quality. The Ramachandran plot, calculated by PRO-CHECK, showed no disallowed residues near the orthosteric or allosteric binding site. The position of the orthosteric ligand NMS is consistent with the interaction fields detected by the different probes implemented in GRID. W84 fills the cavity (Fig. 10A , white transparent silhouette) between the extracellular loops to a great extent. It is remarkable that the phthalimide group diving down into the ligand binding cavity of the receptor (Fig. 9) is positioned between Tyr 177 and Trp 422 (Fig. 10A ), almost in a sandwich-like manner. This position would allow the formation of -interactions between the aromatic residues of the two amino acids and the phthalimide moiety of W84. Hence, an interaction of W84 with both residues at the same time is possible. The narrow corridor between the orthosteric site and the allosteric site is closed and NMS (partially visible in Fig. 10A , bottom) cannot dissociate from the M 2 receptor. 
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In some instances, even maximally effective concentrations of an allosteric agent did not induce complete inhibition of [ 3 H]NMS dissociation (bottom k Ϫ1 significantly higher than k Ϫ1 ϭ 0%). This phenomenon is known for some allosteric agents such as obidoxime and hexamethonium even at wildtype receptors (e.g., Trä nkle and Mohr, 1997; Trä nkle et al., 2005) . We used the double mutant M 2 422 W3Aϩ 423 T3H, in which W84 reduced the probability of [ 3 H]NMS-dissociation at maximum only 4-fold (bottom k Ϫ1 ϭ 24.7%; see Supplemental Table 1 online), to find out whether the model gives a clue about why [ 3 H]NMS dissociation is not completely prevented. A molecular dynamics simulation revealed a higher flexibility of the outer loops, especially o3, and a movement of W84 away from the critical cluster of amino acids. The receptor did not stabilize during the relatively long 6000-ps simulation. A free volume (in the sense of a channel allowing escape of NMS from the W84-occupied receptor) was initially formed but did not persist permanently during the simulation. Figure 10A shows that M 2 423 Thr lines W84 lying in the allosteric cavity. To gain more insight into the postulated detrimental effect of the mutation M 2 423 T3H on W84 binding (see Fig. 4 ), M 2 423 Thr was replaced in the model by histidine. As shown in Fig. 10B , the histidine residue protrudes into the allosteric binding cavity yielding a reduction of space. Thus, M 5 478 His seems to decrease the binding affinity of W84 sterically. Furthermore, the slowing of the [ 3 H]NMS binding kinetics by histidine (see Table 1 ) could be nicely explained by its protrusion into the passage used by NMS to reach and leave the orthosteric site. In conclusion, the results of the docking and molecular dynamics simulation carried out with the current three-dimensional model correspond very well with the experimental findings from the binding assays in the wild-type M 2 and the mutant M 2 receptors.
